Key facts
- This page summarizes Michael Seth Altman's Form 4 filing for Nautilus Biotechnology, Inc. (NAUT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Jun 2024, 18:03.
Michael Seth Altman - 14 Jun 2024 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)
- Reporting relationship
- Director
- Issuer ticker
- NAUT
- Reported as of
- 14 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jun 2024, 18:03:29 UTC
- Prior SEC filing
- 13 Jun 2024
- Next SEC filing
- 31 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Samuel M. Cohn, as Attorney-in-Fact for Michael Seth Altman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Seth Altman filed Form 4 for Nautilus Biotechnology, Inc. (NAUT) on 17 Jun 2024.
Change
- Previous filing in this sequence was filed on 13 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NAUT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +45,000
- Change %
- Price
- $0.000000
- Shares after
- 45,000
- Date
- 14 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,000
- Exercise price
- $2.56
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date.